药物审批工作的过分繁杂,已被当事人批评为“劳民伤财”,美国药品食品管理局(FDA)最近宣布将实施新的改革措施以加快新药审批工作。制药企业非常欢迎这些改革措施,因其不仅降低了审批费用,还可以加快新药进入市场。但批评家则警告说,雇用药厂的工作人员进行自我监督管理,将使他们面临对药 The over-complicated drug approval process has been criticized by the parties as “a waste of money and resources.” The U.S. Food and Drug Administration (FDA) recently announced that it will implement new reform measures to speed up the approval of new drugs. Pharmaceutical companies are very welcome of these reform measures, because they not only reduce the cost of approval, but also can speed up the entry of new drugs into the market. But critics warn that hiring drug factory workers for self-regulation will put them at risk